Almil OTC Drug Manufacturing, Labeling Deficiencies Cited By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA identifies several "serious deviations" from good manufacturing practices in a Feb. 2 warning letter to OTC drug producer Almil Nutritional Products